Authors: | Maron, S. B.; Klempner, S. J. |
Title: | Are you a TMBeliever? Mutations and atezolizumab response in solid tumor |
Abstract: | SUMMARY: Optimizing the utility of tumor mutational burden in solid tumors remains an unmet need and a clinical knowledge gap. Using a centrally determined cutoff of ≥16 mut/Mb, Friedman and colleagues demonstrate an ability to enrich for atezolizumab response in a pretreated pan-cancer multibasket study. See related article by Friedman et al., p. 654 (4). ©2022 American Association for Cancer Research. |
Journal Title: | Cancer Discovery |
Volume: | 12 |
Issue: | 3 |
ISSN: | 2159-8274 |
Publisher: | American Association for Cancer Research |
Date Published: | 2022-03-01 |
Start Page: | 602 |
End Page: | 603 |
Language: | English |
DOI: | 10.1158/2159-8290.Cd-21-1642 |
PUBMED: | 35257152 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Editorial -- Export Date: 1 April 2022 -- Source: Scopus |